PanXome, LLC

PanXome is a pre-clinical, small molecule drug discovery company using "big data" bioinformatics to greatly accelerate and de-risk drug pipelines for pharma.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Atlanta, GA, US
  • Currency USD
  • Founded January 2016
  • Employees 5
  • Incorporation Type LLC
  • Website panxome.com

Company Summary

PanXome is a pre-clinical, small molecule, drug discovery company using "big data" bioinformatics, exclusively licensed from Georgia Tech and fully ready for commercialization. We perform VLS screening, predict side effects, the likelihood of failing a Phase 1 and 2 clinical safety trial and repurpose assets. Two major pharm customers are successfully using our technology. The initial business model is fee-for-service/CRO model.

Team

  • Jack was the founding CEO of N2 Broadband, an Atlanta-based startup which sold for $120 million 5 years after it was founded. He has over 34 years of technology management experience. He served as Licensing Director at Scientific-Atlanta where he negotiated and managed licensing deals with major consumer electronics companies. Jack is active in the Atlanta technology startup community and has served on the BOD of Atlanta Technology Angels.

  • Jeff Skolnick
    CSO

    Dr. Skolnick is the Director of Systems Biology at Georgia Tech with 35 years experience in his field. He is a leader in the field of protein structure & function prediction and is known for his work involving small molecule ligand binding pockets. He has developed best in class virtual screening algorithms to predict drug side effects and for virtual ligand screening. Dr. Skolnick has over 360 peer-reviewed publications and an h-index of 78.

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free